Adherence and Practical Challenges of Long-Term Telerehabilitation in COPD Patients: A Mixed-Method Study.
Permanent lenke
https://hdl.handle.net/10037/18302Dato
2019-05-15Type
Master thesisMastergradsoppgave
Forfatter
Kashif, FalakSammendrag
Telerehabilitation (TR) increases accessibility towards pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD) patients. It appears to be a cost-effective alternative to PR. We aimed to study adherence of COPD patients participating in long-term TR and practical challenges of TR from professional ́s perspective. 40 COPD patients participated in TR for 2 years. Participants performed training exercise and registered their training and daily observations in a webpage. We measured adherence by calculating frequency of registrations. Eight semi-structured interviews with professionals were conducted to explore practical challenges of TR. The Framework Method was used to analyze the qualitative data from these interviews. On average, adherence to training exercise was 1.8 sessions/week (recommended of 3 times/week) and adherence to daily observations was 2.9 registrations/week (recommendation 7 times/week). Six categories were identified by using the framework analysis: acceptance of telerehabilitation by participants and professionals, characteristics of participants, ethical and privacy-related issues, logistic issues, suggestions for improvement, and technical issues. Participants managed to adhere to training exercises and daily registration of symptoms to a great extent, thus integrating TR into their everyday life. Professionals faced many practical challenges, including technical, logistic and Internet-related issues, along with ethical and privacy-related issues. Both participants and professionals accepted and appreciated TR.
Forlag
UiT Norges arktiske universitetUiT The Arctic University of Norway
Metadata
Vis full innførselSamlinger
Copyright 2019 The Author(s)
Følgende lisensfil er knyttet til denne innførselen:
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Relaterte innførsler
Viser innførsler relatert til tittel, forfatter og emneord.
-
Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma : VEGF-A Impact Is Strongly Associated with Ang-2
Andersen, Sigve; Dønnem, Tom; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)Angiopoietins and their receptor Tie-2 are, in concert with VEGF-A, key mediators in angiogenesis. This study evaluates the prognostic impact of all known human angiopoietins (Ang-1, Ang-2 and Ang-4) and their receptor Tie-2, as well as their relation to the prognostic expression of VEGF-A. 335 unselected stage I-IIIA NSCLC-patients were included and tissue samples of respective tumor cells and ... -
The Temporomandibular Joint in Juvenile Idiopathic Arthritis, focusing on Quality of Life, Oral Microbiome and Intervention
Frid, Paula (Doctoral thesis; Doktorgradsavhandling, 2020-10-02)The temporomandibular joint (TMJ) is commonly involved in juvenile idiopathic arthritis (JIA), and may lead to impaired mouth opening, pain and facial growth disturbances. Asymptomatic TMJ arthritis may be diagnosed late in the disease course, thus management is challenging. The overall objectives of this thesis were to provide new knowledge on quality of life (QoL), the oral microbiome and interventions ... -
Humant papillomavirus : en litteraturstudie om HPV, dets relasjon til cancer og tiltak mot videre spredning av virus
Gabrielsen, Endre (Master thesis; Mastergradsoppgave, 2012-06-01)I 1983 oppdaget zur Hausen sammenhengen mellom Humant Papillomavirus (HPV) og livmorhalskreft. På denne tiden visste man ikke at det var HPV som var årsaken til at Helaceller kunne leve in vitro. Ny forskning relaterer HPV til en rekke andre cancertyper. En stor andel anal-, oropharyngeal-, penis-, vaginal-, og vulvacancer skyldes HPV. Det er også påvist HPV i tumorvev fra øsofagus, larynx, lunge, ...